相关实验视频
Updated: Jun 14, 2026

12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.4K
影响初级尤文肉瘤患者的结局的因素
Victor Rechl1, Andreas Ranft1,2, Vivek Bhadri3,4
1Pediatrics III, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Sarcoma
|March 25, 2024
概括
年龄较大,瘤体积较大,以及转移的存在是阴道欧文肉瘤 (EwS) 的不良预后因素. 年轻的患者通常有更好的生存结果,特别是转移性疾病患者.
科学领域:
- 儿科瘤学 儿科瘤学
- 整形瘤学 整形瘤学
- 骨瘤学 骨瘤学
背景情况:
- 尤文肉瘤 (EwS) 是一种罕见的,高度恶性骨瘤,主要影响年轻人.
- 圣体EWS异常罕见,由于解剖学复杂性,对局部治疗构成重大挑战.
研究的目的:
- 为了确定影响阴部欧文肉瘤患者的预后因素影响结果.
- 分析年龄,瘤体积和转移状态对生存的影响.
主要方法:
- 从GPOH EURO-E.W.I.N.G 99和EWING 2008试验中对124名局部或转移的圣殿EWS患者进行了回顾性分析.
- 总生存率 (OS) 和无事件生存率 (EFS) 用卡普兰-梅尔法计算.
- 多变量考克斯回归模型用于估计危险比率 (HR) 和95%置信区间 (CI).
主要成果:
- 转移,大瘤体积 (≥200ml) 和年龄≥18岁被确定为不良预后因素.
- 转移患者的3年EFS (0.33比0.68) 和OS (0.48比0.85) 显著降低.
- 年龄较大 (≥18岁) 与EFS (0.41比0.60) 和OS (0.294比0.59) 较差有关.
结论:
- 年轻的年龄是圣体EWS存活的积极预后因素,特别是在转移病例中.
- 瘤体积,转移的存在和局部治疗影响患者的结果.
- 这些发现支持先前的研究表明,年龄较大对骨EWS的存活率产生负面影响.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

